In the BioHarmony Drug Report Database
Fluorouracil
Adrucil, Carac, Efudex, Fluoroplex, Fluorouracil, Tolak (fluorouracil) is a small molecule pharmaceutical. Fluorouracil was first approved as Adrucil on 1982-01-01. It is used to treat basal cell carcinoma, breast neoplasms, colonic neoplasms, head and neck neoplasms, and keratosis amongst others in the USA. Efudex’s patents are valid until 2023-07-18 (FDA).
Trade Name
|
Adrucil, Carac, Efudex, Fluoroplex, Fluorouracil, Tolak |
|---|---|
Common Name
|
fluorouracil |
ChEMBL ID
|
CHEMBL185 |
Indication
|
basal cell carcinoma, breast neoplasms, colonic neoplasms, head and neck neoplasms, keratosis, pancreatic neoplasms, rectal neoplasms, stomach neoplasms |
Drug Class
|
Uracil type antineoplastics; uracil derivatives used as thyroid antagonists and as antineoplastics |
Image (chem structure or protein)